Sophie Kornowski, Ph.D., Partner at Gurnet Point Capital, and Doug Giordano, Managing Director, Perceptive Advisors speak with Yaron Werber, M.D., Biotechnology Analyst. They discuss how they thought through valuations when they headed transactions at Roche and Pfizer, the importance of taking risks, and staying humble. They also speak about the importance of building relationships, getting internal alignment and support for deals, and offer a behind-the-scenes look at how deals are done.
Press play to listen to the podcast.
Get the Full Report
If you’re already a member of our Research portal, log in.Log In
If not, reach out to us directly for more information.